Medmira Capital Ltd. - Net Worth and Insider Trading

Medmira Capital Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Medmira Capital Ltd. owns 1 companies in total, including HCW Biologics Inc (HCWB) .

Click here to see the complete history of Medmira Capital Ltd.’s form 4 insider trades.

Insider Ownership Summary of Medmira Capital Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
HCWB	HCW Biologics Inc	2021-07-19	10 percent owner

Medmira Capital Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Medmira Capital Ltd. Ownership Network

Ownership Network List of Medmira Capital Ltd.

No Data

Ownership Network Relation of Medmira Capital Ltd.

Medmira Capital Ltd. Owned Company Details

What does HCW Biologics Inc do?

Who are the key executives at HCW Biologics Inc?

Medmira Capital Ltd. is the 10 percent owner of HCW Biologics Inc. Other key executives at HCW Biologics Inc include director & Chief Executive Officer Hing C Wong , Chief Financial Officer Rebecca Byam , and SVP of Business Development Lee Flowers .

HCW Biologics Inc (HCWB) Insider Trades Summary

Over the past 18 months, Medmira Capital Ltd. made no insider transaction in HCW Biologics Inc (HCWB). Other recent insider transactions involving HCW Biologics Inc (HCWB) include a net purchase of 212,244 shares made by Rebecca Byam , a net purchase of 4,000 shares made by Gary M Winer , and a net purchase of 8,400 shares made by Hing C Wong .

In summary, during the past 3 months, insiders sold 0 shares of HCW Biologics Inc (HCWB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HCW Biologics Inc (HCWB) were sold and 234,644 shares were bought by its insiders, resulting in a net purchase of 234,644 shares.

HCW Biologics Inc (HCWB)'s detailed insider trading history can be found in Insider Trading Tracker table.

HCW Biologics Inc Insider Transactions

No Available Data

Medmira Capital Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Medmira Capital Ltd.. You might contact Medmira Capital Ltd. via mailing address: 16f Beike Building, 59 Gaoxin Nanjiu Rd, Shenzhen F4 518057.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.